The University of Chicago Header Logo

Connection

Hedy Kindler to Bridged Bicyclo Compounds, Heterocyclic

Back to Details
This is a "connection" page, showing publications Hedy Kindler has written about Bridged Bicyclo Compounds, Heterocyclic.
Hedy Kindler
Connection Strength
0.189
Bridged Bicyclo Compounds, Heterocyclic
  1. Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors. Clin Cancer Res. 2016 06 15; 22(12):2874-84.
    View in: PubMed
    Score: 0.127
  2. PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma. Sci Rep. 2016 09 13; 6:32992.
    View in: PubMed
    Score: 0.033
  3. MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma. PLoS One. 2014; 9(9):e105919.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.